Log Type Authored on Log Message Log Node Authored by
Newsletter opened Opened Anonymous
Newsletter opened Opened É Amanhã! Aula médica "Os desafios da funcionalidade em pacientes com TDM na prática clínica" Anonymous
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened É Amanhã! Aula médica "Os desafios da funcionalidade em pacientes com TDM na prática clínica" Anonymous
Newsletter opened Opened Anonymous
Newsletter clicked Clicked https://japan.progress.im/ja/content/covid-19%E6%84%9F%E6%9F%93%E6%8B%A1%E5%A4%A7%E4%B8%8B%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E3%81%86%E3%81%A4%E7%97%85%E3%81%AE%E3%83%AA%E3%83%AF%E3%83%BC%E3%82%AF%E3%83%97%E3%83%AD%E3%82%B0%E3%83%A9%E3%83%A0%E3%81% Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
User created User created Anonymous
OWA Status israel@progress.im manually updating trust level from 1 to 5 Anonymous
OWA Status israel@progress.im manually updating trust level from 1 to 5 Anonymous
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Anonymous
User created User created Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened É Amanhã! Aula médica "Os desafios da funcionalidade em pacientes com TDM na prática clínica" Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter clicked Clicked https://japan.progress.im/ja/content/covid-19%E3%81%AB%E3%82%88%E3%82%8B%E5%85%A5%E9%99%A2%E6%82%A3%E8%80%85%E3%81%AE%E6%AD%BB%E4%BA%A1%E7%8E%87%E4%B8%8A%E6%98%87%E3%81%AB%E5%85%A5%E9%99%A2%E5%89%8D%E3%81%AE%E7%B2%BE%E7%A5%9E%E7%96%BE%E6%82%A3%E8%A8% Anonymous
Newsletter clicked Clicked https://japan.progress.im/ja/content/covid-19%E3%83%91%E3%83%B3%E3%83%87%E3%83%9F%E3%83%83%E3%82%AF%E4%B8%AD%E3%81%AE%E7%B1%B3%E5%9B%BD%E3%80%81%E9%81%A0%E9%9A%94%E5%BF%83%E7%90%86%E8%A8%BA%E7%99%82%EF%BC%88%E5%BF%83%E7%90%86%E7%99%82%E6%B3%95%E3%83% Anonymous
Log Type Authored on Log Message Log Node Authored by
Newsletter opened Opened Anonymous
Newsletter opened Opened É Amanhã! Aula médica "Os desafios da funcionalidade em pacientes com TDM na prática clínica" Anonymous
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened É Amanhã! Aula médica "Os desafios da funcionalidade em pacientes com TDM na prática clínica" Anonymous
Newsletter opened Opened Anonymous
Newsletter clicked Clicked https://japan.progress.im/ja/content/covid-19%E6%84%9F%E6%9F%93%E6%8B%A1%E5%A4%A7%E4%B8%8B%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E3%81%86%E3%81%A4%E7%97%85%E3%81%AE%E3%83%AA%E3%83%AF%E3%83%BC%E3%82%AF%E3%83%97%E3%83%AD%E3%82%B0%E3%83%A9%E3%83%A0%E3%81% Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
User created User created Anonymous
OWA Status israel@progress.im manually updating trust level from 1 to 5 Anonymous
OWA Status israel@progress.im manually updating trust level from 1 to 5 Anonymous
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Anonymous
User created User created Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened É Amanhã! Aula médica "Os desafios da funcionalidade em pacientes com TDM na prática clínica" Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter clicked Clicked https://japan.progress.im/ja/content/covid-19%E3%81%AB%E3%82%88%E3%82%8B%E5%85%A5%E9%99%A2%E6%82%A3%E8%80%85%E3%81%AE%E6%AD%BB%E4%BA%A1%E7%8E%87%E4%B8%8A%E6%98%87%E3%81%AB%E5%85%A5%E9%99%A2%E5%89%8D%E3%81%AE%E7%B2%BE%E7%A5%9E%E7%96%BE%E6%82%A3%E8%A8% Anonymous
Newsletter clicked Clicked https://japan.progress.im/ja/content/covid-19%E3%83%91%E3%83%B3%E3%83%87%E3%83%9F%E3%83%83%E3%82%AF%E4%B8%AD%E3%81%AE%E7%B1%B3%E5%9B%BD%E3%80%81%E9%81%A0%E9%9A%94%E5%BF%83%E7%90%86%E8%A8%BA%E7%99%82%EF%BC%88%E5%BF%83%E7%90%86%E7%99%82%E6%B3%95%E3%83% Anonymous